Benjamin Bonavida

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 5

Top Topics

Multiple Myeloma

Endoplasmic Reticulum Stress

Top Venues

Exploration of targeted anti-tumor therapy

Journal of experimental & clinical cancer research : CR

Antioxidants & redox signaling

This page only lists publications with an associated author ORCID identifier.

Publications

Indy Bui, Stavroula Baritaki, Massimo Libra, Apostolos Zaravinos, Benjamin Bonavida
Cancer Resistance Is Mediated by the Upregulation of Several Anti-Apoptotic Gene Products via the Inducible Nitric Oxide Synthase/Nitric Oxide Pathway: Therapeutic Implications. Antioxidants & redox signaling (2023)
Matthew Moghaddam, Silvia Vivarelli, Luca Falzone, Massimo Libra, Benjamin Bonavida
Cancer resistance via the downregulation of the tumor suppressors RKIP and PTEN expressions: therapeutic implications. Exploration of targeted anti-tumor therapy 4 (2) (2023)
Matthew Moghaddam, Silvia Vivarelli, Luca Falzone, Massimo Libra, Benjamin Bonavida
Cancer resistance via the downregulation of the tumor suppressors RKIP and PTEN expressions: therapeutic implications. Exploration of targeted anti-tumor therapy 4 (2) (2023)
Matthew Moghaddam, Silvia Vivarelli, Luca Falzone, Massimo Libra, Benjamin Bonavida
Cancer resistance via the downregulation of the tumor suppressors RKIP and PTEN expressions: therapeutic implications. Exploration of targeted anti-tumor therapy 4 (2) (2023)
Anna Shvartsur, Kevin B Givechian, Hermes Garban, Benjamin Bonavida
Overexpression of RKIP and its cross-talk with several regulatory gene products in multiple myeloma. Journal of experimental & clinical cancer research : CR 36 (1) (2017)